Humacyte to Provide Investor Update on June 7

Durham, N.C. – June 4, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7 …

Humacyte to Provide Investor Update on June 7 Read More »